Completed PHASE3 INTERVENTIONAL 1-arm NCT01762904

Residual Effect of Chlorhexidine-alcohol Compared to Triclosan-alcohol

Residual Effect of Chlorhexidine 2% / Isopropyl Alcohol 70% Compared to Triclosan 1% / Isopropyl Alcohol 70%

Sponsor: Antisepsia Central

Interventions Bacterial culture of the prepared skin's areas with two antiseptics and two controls Preparing skin's areas to be tested with two antiseptics and two controls

Updated 8 times since 2017 Last updated: Jun 1, 2014 Started: Jan 31, 2013 Primary completion: Apr 30, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01762904, this PHASE3 trial focuses on Infectious Diseases and remains completed. Sponsored by Antisepsia Central, it has been updated 8 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Antisepsia Central
Universidad de Guanajuato

Data source: Universidad de Guanajuato

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• León, Mexico